Division of Women's Health Internal Medicine, Mayo Clinic, Scottsdale/Phoenix, AZ, USA; Mayo Clinic Women's Health, Rochester, MN, USA.
Mayo Clinic Alix School of Medicine, Scottsdale/Phoenix, AZ, USA.
J Sex Med. 2022 Oct;19(10):1553-1561. doi: 10.1016/j.jsxm.2022.07.009. Epub 2022 Aug 13.
Studies have found that women with endometriosis have a higher risk of female sexual dysfunction (FSD).
To evaluate the relationship between self-reported endometriosis and FSD utilizing validated surveys.
A cross-sectional analysis was conducted among sexually active women aged 18-90 who presented to 3 Mayo Clinic sites from 2015 to 2021. FSD was determined utilizing a combined endpoint of Female Sexual Function Index score ≤ 26.55 and Female Sexual Distress Scale-Revised score ≥ 11. Associations between history of endometriosis and FSD were evaluated by fitting 3 multivariable logistic models and were stratified by menopause status. In the first model, the association was adjusted for age, BMI, race/ethnicity, marital status, and education. The second model adjusted for the variables in Model 1 and hormone therapy, hormonal contraceptive use, self-reported history of abuse within the last year, and co-morbidities including the history of diabetes, heart disease, hypertension, osteoporosis, and stroke. The third model adjusted for the variables in Model 1, Model 2, and anxiety, depression, relationship satisfaction, and SSRI/SNRI use.
The outcomes included self-reported endometriosis and female sexual dysfunction determined utilizing a combined endpoint of Female Sexual Function Index score ≤ 26.55 and Female Sexual Distress Scale-Revised score ≥ 11.
Of 7118 patients (mean age 51.3), 92.2% were white, 78.4% were peri- or postmenopausal, 8.7% reported endometriosis history, and 57.2% met the criteria for FSD. Women with endometriosis were more likely to be overweight or obese, be smokers, have had a history of heart disease and osteoporosis, have had anxiety and depressed mood, have had a hysterectomy and bilateral salpingo-oophorectomy, and have used hormone therapy. Compared to those without endometriosis, women with endometriosis were significantly more likely to have FSD only among premenopausal women (74.2% vs 57.4%). Similarly, in multivariable analysis the relationship was only seen for premenopausal women in all 3 models (Model 1: OR 2.74 (95% CI 1.43-5.27); Model 2: OR 2.55 (95% CI 1.30-5.04); Model 3: OR 2.30 (95% CI 1.13-4.68)).
These findings highlight the opportunity for healthcare practitioners to evaluate sexual function in premenopausal women with endometriosis. For peri and postmenopausal women with endometriosis, the risk of FSD was lower than for premenopausal women with endometriosis.
This study analyzed the association between endometriosis and FSD in women by menopause status using validated tools that included a measure of distress associated with sexual dysfunction. Limitations include its cross-sectional design which does not allow for determination of the direction of this association.
The risk for FSD associated with endometriosis depends on menopause status. Endometriosis increased the odds of FSD only in premenopausal women. Kling JM, Ghaith S, Smith T, et al. Evaluating the Link Between Self-Reported Endometriosis and Female Sexual Dysfunction. J Sex Med 2022;19:1533-1561.
研究发现,子宫内膜异位症患者女性性功能障碍(FSD)的风险更高。
利用经过验证的调查评估自我报告的子宫内膜异位症与 FSD 之间的关系。
对 2015 年至 2021 年期间在梅奥诊所的 3 个地点就诊的年龄在 18 至 90 岁之间有性生活的女性进行了横断面分析。利用女性性功能指数评分≤26.55 和女性性困扰量表修订版评分≥11 的联合终点来确定 FSD。通过拟合 3 个多变量逻辑模型来评估子宫内膜异位症病史与 FSD 之间的关联,并按绝经状态进行分层。在第一个模型中,关联是在调整年龄、BMI、种族/民族、婚姻状况和教育程度后进行的。第二个模型调整了模型 1 中的变量,以及激素治疗、激素避孕药的使用、过去一年中自我报告的滥用史以及包括糖尿病、心脏病、高血压、骨质疏松症和中风病史在内的共病。第三个模型调整了模型 1、模型 2 中的变量,以及焦虑、抑郁、关系满意度和 SSRI/SNRI 的使用。
在 7118 名患者(平均年龄 51.3 岁)中,92.2%为白人,78.4%为围绝经期或绝经后,8.7%报告有子宫内膜异位症病史,57.2%符合 FSD 标准。患有子宫内膜异位症的女性更可能超重或肥胖、吸烟、患有心脏病和骨质疏松症病史、患有焦虑和抑郁情绪、接受过子宫切除术和双侧输卵管卵巢切除术,以及使用过激素治疗。与没有子宫内膜异位症的女性相比,有子宫内膜异位症的女性在绝经前女性中更有可能出现 FSD(74.2%比 57.4%)。同样,在多变量分析中,在所有 3 个模型中,仅在绝经前女性中观察到这种关系(模型 1:比值比 2.74(95%CI 1.43-5.27);模型 2:比值比 2.55(95%CI 1.30-5.04);模型 3:比值比 2.30(95%CI 1.13-4.68))。
这些发现强调了医疗保健提供者有机会在患有子宫内膜异位症的绝经前女性中评估性功能。对于患有子宫内膜异位症的围绝经期和绝经后女性,FSD 的风险低于患有子宫内膜异位症的绝经前女性。
本研究通过使用包括与性功能障碍相关的困扰测量在内的经过验证的工具,按绝经状态分析了子宫内膜异位症与 FSD 之间的关联。局限性包括其横断面设计,不允许确定这种关联的方向。
与子宫内膜异位症相关的 FSD 风险取决于绝经状态。子宫内膜异位症仅在绝经前女性中增加了 FSD 的几率。